Staging, Treatment, and Future Approaches of Gallbladder Carcinoma

J Gastrointest Cancer. 2018 Mar;49(1):9-15. doi: 10.1007/s12029-017-0036-5.

Abstract

Background: Gallbladder cancer is the most common malignant cancer of the bile ducts and third most common gastrointestinal malignant in the world for public health. Its relatively low incidence and confused symptoms result in advanced disease at the time of presentation, contributing to poor prognosis and reduced survival associated with this disease. The main function of the gallbladder is to store excreted bile acids from the liver in preparation for a meal. Its main risk factor is prolonged exposure to biliary calculations, although bacterial infections and other inflammatory conditions are associated. Chronic inflammatory bowel conditions are associated with gallbladder cancer. T stage translates to identifying residual disease at reoperation for incidental gallbladder cancer and residual disease negatively affects survival.

Conclusion: It is the most common cancer of gallbladder, gallbladder cancer remains a rare disease. Gallbladder cancer is a rare disease that can be accidentally diagnosed after cholecystectomy or accidentally, often with more advanced disease. The prognosis is generally extremely poor and improvements in surgical resection of this approach have to be re-evaluated, while the role of chemotherapy and radiotherapy remains controversial.

Keywords: Carcinoma; Cholecystectomy; Gallbladder; Staging; Treatment.

Publication types

  • Review

MeSH terms

  • Cholecystectomy / methods*
  • Female
  • Gallbladder Neoplasms / drug therapy*
  • Gallbladder Neoplasms / pathology
  • Gallbladder Neoplasms / therapy*
  • Humans
  • Male
  • Neoplasm Staging
  • Prognosis
  • Risk Factors